Skip to main content
. 2019 Feb 20;120(6):633–639. doi: 10.1038/s41416-019-0396-7

Fig. 5.

Fig. 5

Survival analysis (Kaplan–Meier estimates) for APLNR protein expression in patients with clear-cell renal cell carcinoma (immunohistochemistry cohort), overall survival as endpoint. a APLNR expression on tumoural vessels; staining intensity: “0”—negative, “1”—weak expression, “2”—moderate expression, “3”—strong expression. b APLNR expression in cytoplasm of tumour cells; staining intensity (“0” negative, “1” weak expression, “2” moderate expression, “3” strong expression)